Literature DB >> 21640735

Sex difference in sensitivity to allopregnanolone neuroprotection in mice correlates with effect on spontaneous inhibitory post synaptic currents.

Melissa H Kelley1, Masayuki Kuroiwa, Noriko Taguchi, Paco S Herson.   

Abstract

Allopregnanolone (ALLO) is a neurosteroid that has many functions in the brain, most notably neuroprotection and modulation of gamma-amino butyric acid (GABA) neurotransmission. Using a mouse model of cardiac arrest and cardiopulmonary resuscitation, we have previously demonstrated that ALLO protects cerebellar Purkinje cells (PCs) from ischemia in a GABA(A) receptor-dependent manner. In this study we examined the effect of sex on ALLO neuroprotection, observing that low dose ALLO (2 mg/kg) provided greater neuroprotection in females compared to males. At a higher dose of ALLO (8 mg/kg), both sexes were significantly protected from ischemic damage. Using an acute cerebellar slice preparation, whole cell voltage clamp recordings were made from PCs. Spontaneous inhibitory post synaptic currents (IPSCs) were analyzed and the response to physiological ALLO (10 nM) was significantly greater in female PCs compared to male. In contrast, recordings of miniature IPSCs, did not exhibit a sex difference in response to ALLO, suggesting that ALLO affects males and females differentially through a mechanism other than binding postsynaptic GABA(A) receptors. We conclude that the female brain has greater sensitivity to ALLO mediated potentiation of GABAergic neurotransmission, contributing to increased neuroprotection.
Copyright © 2011 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21640735      PMCID: PMC3133674          DOI: 10.1016/j.neuropharm.2011.05.017

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  33 in total

Review 1.  Biosynthesis of neurosteroids and regulation of their synthesis.

Authors:  S H Mellon; H Vaudry
Journal:  Int Rev Neurobiol       Date:  2001       Impact factor: 3.230

2.  Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration.

Authors:  L C Schmued; K J Hopkins
Journal:  Brain Res       Date:  2000-08-25       Impact factor: 3.252

3.  Oxytocin regulates neurosteroid modulation of GABA(A) receptors in supraoptic nucleus around parturition.

Authors:  Jan-Jurjen Koksma; Ronald E van Kesteren; Thomas W Rosahl; Ruud Zwart; August B Smit; Hartmut Lüddens; Arjen B Brussaard
Journal:  J Neurosci       Date:  2003-02-01       Impact factor: 6.167

4.  On the putative physiological role of allopregnanolone on GABA(A) receptor function.

Authors:  G Puia; J-M Mienville; K Matsumoto; H Takahata; H Watanabe; E Costa; A Guidotti
Journal:  Neuropharmacology       Date:  2003-01       Impact factor: 5.250

5.  Heart disease and stroke statistics--2011 update: a report from the American Heart Association.

Authors:  Véronique L Roger; Alan S Go; Donald M Lloyd-Jones; Robert J Adams; Jarett D Berry; Todd M Brown; Mercedes R Carnethon; Shifan Dai; Giovanni de Simone; Earl S Ford; Caroline S Fox; Heather J Fullerton; Cathleen Gillespie; Kurt J Greenlund; Susan M Hailpern; John A Heit; P Michael Ho; Virginia J Howard; Brett M Kissela; Steven J Kittner; Daniel T Lackland; Judith H Lichtman; Lynda D Lisabeth; Diane M Makuc; Gregory M Marcus; Ariane Marelli; David B Matchar; Mary M McDermott; James B Meigs; Claudia S Moy; Dariush Mozaffarian; Michael E Mussolino; Graham Nichol; Nina P Paynter; Wayne D Rosamond; Paul D Sorlie; Randall S Stafford; Tanya N Turan; Melanie B Turner; Nathan D Wong; Judith Wylie-Rosett
Journal:  Circulation       Date:  2010-12-15       Impact factor: 29.690

6.  Effects of a naturally occurring neurosteroid on GABAA IPSCs during development in rat hippocampal or cerebellar slices.

Authors:  E J Cooper; G A Johnston; F A Edwards
Journal:  J Physiol       Date:  1999-12-01       Impact factor: 5.182

7.  Out-of-hospital cardiac arrest in men and women.

Authors:  C Kim; C E Fahrenbruch; L A Cobb; M S Eisenberg
Journal:  Circulation       Date:  2001-11-27       Impact factor: 29.690

8.  Sex-related differences in the presentation and outcome of out-of-hospital cardiopulmonary arrest: a multiyear, prospective, population-based study.

Authors:  Jane G Wigginton; Paul E Pepe; John P Bedolla; Lucy A DeTamble; James M Atkins
Journal:  Crit Care Med       Date:  2002-04       Impact factor: 7.598

9.  A mouse model of episodic ataxia type-1.

Authors:  Paco S Herson; Michael Virk; Nathan R Rustay; Chris T Bond; John C Crabbe; John P Adelman; James Maylie
Journal:  Nat Neurosci       Date:  2003-04       Impact factor: 24.884

10.  GABA(A) receptor delta subunit deletion prevents neurosteroid modulation of inhibitory synaptic currents in cerebellar neurons.

Authors:  Stefano Vicini; Gabriele Losi; Gregg E Homanics
Journal:  Neuropharmacology       Date:  2002-09       Impact factor: 5.250

View more
  11 in total

Review 1.  Sex differences in the anticonvulsant activity of neurosteroids.

Authors:  Doodipala Samba Reddy
Journal:  J Neurosci Res       Date:  2017-01-02       Impact factor: 4.164

Review 2.  Neurosteroid interactions with synaptic and extrasynaptic GABA(A) receptors: regulation of subunit plasticity, phasic and tonic inhibition, and neuronal network excitability.

Authors:  Chase Matthew Carver; Doodipala Samba Reddy
Journal:  Psychopharmacology (Berl)       Date:  2013-09-27       Impact factor: 4.530

Review 3.  Synthetic neuroactive steroids as new sedatives and anaesthetics: Back to the future.

Authors:  Francesca M Manzella; Douglas F Covey; Vesna Jevtovic-Todorovic; Slobodan M Todorovic
Journal:  J Neuroendocrinol       Date:  2022-01-10       Impact factor: 3.627

4.  Sexually dimorphic response of TRPM2 inhibition following cardiac arrest-induced global cerebral ischemia in mice.

Authors:  S Nakayama; R Vest; R J Traystman; P S Herson
Journal:  J Mol Neurosci       Date:  2013-03-27       Impact factor: 3.444

5.  Alterations in Purkinje cell GABAA receptor pharmacology following oxygen and glucose deprivation and cerebral ischemia reveal novel contribution of β1 -subunit-containing receptors.

Authors:  Melissa H Kelley; Justin Ortiz; Kaori Shimizu; Himmat Grewal; Nidia Quillinan; Paco S Herson
Journal:  Eur J Neurosci       Date:  2012-11-26       Impact factor: 3.386

6.  The neurosteroid allopregnanolone modulates specific functions in central and peripheral glial cells.

Authors:  Alessandro Faroni; Valerio Magnaghi
Journal:  Front Endocrinol (Lausanne)       Date:  2011-12-28       Impact factor: 5.555

Review 7.  Frontiers in therapeutic development of allopregnanolone for Alzheimer's disease and other neurological disorders.

Authors:  Ronald W Irwin; Christine M Solinsky; Roberta Diaz Brinton
Journal:  Front Cell Neurosci       Date:  2014-07-30       Impact factor: 5.505

8.  Therapeutic effects of progesterone and its metabolites in traumatic brain injury may involve non-classical signaling mechanisms.

Authors:  Paul S Cooke; Manjunatha K Nanjappa; Zhihui Yang; Kevin K W Wang
Journal:  Front Neurosci       Date:  2013-06-13       Impact factor: 4.677

Review 9.  Allopregnanolone: An overview on its synthesis and effects.

Authors:  Silvia Diviccaro; Lucia Cioffi; Eva Falvo; Silvia Giatti; Roberto Cosimo Melcangi
Journal:  J Neuroendocrinol       Date:  2021-06-29       Impact factor: 3.870

Review 10.  Neurosteroid Metabolites of Gonadal Steroid Hormones in Neuroprotection: Implications for Sex Differences in Neurodegenerative Disease.

Authors:  Ari Loren Mendell; Neil James MacLusky
Journal:  Front Mol Neurosci       Date:  2018-10-05       Impact factor: 5.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.